Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis

Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
doi: https://doi.org/10.1101/2020.10.28.20216887
Fritz Sörgel
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
2Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakob J. Malin
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
5German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henning Hagmann
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
6Department II of Internal Medicine, University Hospital Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Kinzig
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Bilal
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis A. Eichenauer
8University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Intensive Care Program, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Scherf-Clavel
1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
9University of Wuerzburg, Institute for Pharmacy and Food Chemistry, Wuerzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Simonis
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lobna El Tabei
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uwe Fuhr
7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.rybniker@uk-koeln.de uwe.fuhr@uk-koeln.de
Jan Rybniker
3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
5German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.rybniker@uk-koeln.de uwe.fuhr@uk-koeln.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2020.10.28.20216887
History 
  • November 3, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Fritz Sörgel1,2,*,
  2. Jakob J. Malin3,4,5,*,
  3. Henning Hagmann4,6,
  4. Martina Kinzig1,
  5. Muhammad Bilal7,
  6. Dennis A. Eichenauer8,
  7. Oliver Scherf-Clavel1,9,
  8. Alexander Simonis3,4,
  9. Lobna El Tabei7,
  10. Uwe Fuhr7,# and
  11. Jan Rybniker3,4,5,#
  1. 1IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, D-90562 Nürnberg-Heroldsberg, Germany
  2. 2Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany
  3. 3Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany
  4. 4Faculty of Medicine, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
  5. 5German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
  6. 6Department II of Internal Medicine, University Hospital Cologne, Cologne, Germany
  7. 7Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Department I of Pharmacology, University of Cologne, Cologne, Germany
  8. 8University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Intensive Care Program, Cologne, Germany
  9. 9University of Wuerzburg, Institute for Pharmacy and Food Chemistry, Wuerzburg, Germany
  1. ↵#corresponding authors: Jan Rybniker, M.D., Ph.D.; ID-specialist, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine; Division of Infectious Diseases, University of Cologne, Cologne, Germany, Email: jan.rybniker{at}uk-koeln.de, Uwe Fuhr, M.D.; Professor of Pharmacoloy, Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, Acting Director, Department I of Pharmacology, University of Cologne, Cologne, Germany, Email: uwe.fuhr{at}uk-koeln.de
  1. ↵* authors contributed equally

Back to top
PreviousNext
Posted November 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
medRxiv 2020.10.28.20216887; doi: https://doi.org/10.1101/2020.10.28.20216887
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent hemodialysis
Fritz Sörgel, Jakob J. Malin, Henning Hagmann, Martina Kinzig, Muhammad Bilal, Dennis A. Eichenauer, Oliver Scherf-Clavel, Alexander Simonis, Lobna El Tabei, Uwe Fuhr, Jan Rybniker
medRxiv 2020.10.28.20216887; doi: https://doi.org/10.1101/2020.10.28.20216887

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (164)
  • Allergy and Immunology (417)
  • Anesthesia (93)
  • Cardiovascular Medicine (867)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (398)
  • Epidemiology (8597)
  • Forensic Medicine (4)
  • Gastroenterology (391)
  • Genetic and Genomic Medicine (1775)
  • Geriatric Medicine (170)
  • Health Economics (376)
  • Health Informatics (1252)
  • Health Policy (625)
  • Health Systems and Quality Improvement (472)
  • Hematology (198)
  • HIV/AIDS (380)
  • Infectious Diseases (except HIV/AIDS) (10354)
  • Intensive Care and Critical Care Medicine (554)
  • Medical Education (193)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1692)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (330)
  • Occupational and Environmental Health (451)
  • Oncology (934)
  • Ophthalmology (265)
  • Orthopedics (104)
  • Otolaryngology (172)
  • Pain Medicine (115)
  • Palliative Medicine (40)
  • Pathology (256)
  • Pediatrics (541)
  • Pharmacology and Therapeutics (257)
  • Primary Care Research (210)
  • Psychiatry and Clinical Psychology (1788)
  • Public and Global Health (3877)
  • Radiology and Imaging (629)
  • Rehabilitation Medicine and Physical Therapy (324)
  • Respiratory Medicine (525)
  • Rheumatology (208)
  • Sexual and Reproductive Health (171)
  • Sports Medicine (159)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)